tiprankstipranks
Advertisement
Advertisement
ProQR Raises $59 Million in Equity Offering and Eli Lilly Private Placement
PremiumCompany AnnouncementsProQR Raises $59 Million in Equity Offering and Eli Lilly Private Placement
1M ago
ProQR Therapeutics price target lowered to $10 from $11 at JonesResearch
Premium
The Fly
ProQR Therapeutics price target lowered to $10 from $11 at JonesResearch
1M ago
ProQR Therapeutics price target lowered to $3 from $4 at Chardan
Premium
The Fly
ProQR Therapeutics price target lowered to $3 from $4 at Chardan
1M ago
ProQR: Buy Rating Reiterated as Axiomer Pipeline Progress and Upcoming Catalysts Support Unchanged $12 Price Target
PremiumRatingsProQR: Buy Rating Reiterated as Axiomer Pipeline Progress and Upcoming Catalysts Support Unchanged $12 Price Target
3M ago
ProQR Posts Q1 2026 Results as Axiomer RNA Editing Pipeline Advances
Premium
Company Announcements
ProQR Posts Q1 2026 Results as Axiomer RNA Editing Pipeline Advances
3M ago
ProQR Posts Wider Q1 2026 Loss but Maintains Strong Cash Position
Premium
Company Announcements
ProQR Posts Wider Q1 2026 Loss but Maintains Strong Cash Position
3M ago
ProQR Details Axiomer Pipeline Expansion and New Liver and Genetic Disease Programs
PremiumCompany AnnouncementsProQR Details Axiomer Pipeline Expansion and New Liver and Genetic Disease Programs
4M ago
ProQR Partners with Ginkgo Bioworks, Launches AI Advisory Board to Drive Axiomer RNA Drug Discovery
Premium
Company Announcements
ProQR Partners with Ginkgo Bioworks, Launches AI Advisory Board to Drive Axiomer RNA Drug Discovery
4M ago
Oppenheimer Predicts Up to ~560% Rally for These 2 ‘Strong Buy’ Stocks
Premium
Stock Analysis & Ideas
Oppenheimer Predicts Up to ~560% Rally for These 2 ‘Strong Buy’ Stocks
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100